29th Jul 2020 06:59
OKYO Pharma Ltd - London-based life sciences and biotechnology company - Issued convertible loan notes at a compounding interest rate of 2.2% with a maximum term of four years at 8.5 pence each to raise GBP3.5 million. Okyo plans on using the proceeds to further develop its clinical pipeline.
Current stock price: 11.00 pence
Year-to-date change: up sharply from 1.7p at the end of 2019
By Greg Roxburgh; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
OKYO.L